Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, March 16, 2026

Protein changes could predict post-stroke cognitive decline

 So what? WHAT EXACTLY WILL PREVENT COGNITIVE DECLINE? You have no fucking idea on research needs in stroke! The only goal in stroke is 100% recovery! Do the research that gets there or you're fired!  Your mentors and senior researchers are obviously incompetent!

Protein changes could predict post-stroke cognitive decline

Protein changes after stroke could help identify people at risk of later memory and thinking problems, new research study suggests.

The study also suggests smoking may increase the risk of memory and thinking problems alongside ongoing inflammation after a stroke.

The research, published in Alzheimer’s & Dementia, is part of the Stroke IMPaCT study, a network of European and North American researchers working to discover how inflammation and immune responses contribute to post-stroke cognitive decline.

Lead author Natasha Carmichael, an MBPhD researcher at The University of Manchester, said: “Inflammation after stroke doesn’t just happen once and disappear. By tracking this protein over time, we may be able to identify patients at greater risk of cognitive problems and eventually tailor support or treatments to them.”

The team followed patients treated for an ischaemic stroke at Salford Royal Hospital, part of Northern Care Alliance NHS Foundation Trust.

They measured levels of interleukin-6, or IL-6, in the days after stroke and again at both six to nine and 18 to 21 months. Participants also completed detailed tests of memory and thinking.

Interleukin-6 levels increased soon after stroke and, in most people, fell back to typical levels within six to nine months. But in some patients, levels stayed high or rose again.

These individuals were about eight times more likely to develop difficulties with thinking ability.

The researchers also saw differences between smokers and non-smokers. Smokers showed a different pattern of IL-6 change after stroke, with signs of longer-lasting inflammation.

This ongoing inflammation was more strongly linked to problems with thinking and memory.

Craig Smith, professor of stroke medicine at The University of Manchester and consultant at Salford Royal, said: “Our findings suggest it’s not just the initial spike in inflammation that matters, it’s whether it properly settles down after the stroke.

“Smoking appears to interfere with this recovery, leaving people more vulnerable to memory and thinking problems.”

Stuart Allan added: “When the immune system’s recovery after stroke doesn’t occur as expected, patients appear more likely to experience cognitive difficulties.

“If future studies confirm interleukin-6 is the cause, we might one day use medications that block it to protect brain health.”

No comments:

Post a Comment